Comparing treatment strategies for heart failure: a real-world analysis of adding ARNI or SGLT2i to older GDMT

被引：0
|
作者：
Amornritvanich, P. [1 ]
Numthavaj, P. [1 ]
Anothaisintawee, T. [1 ]
Tansawet, A. [2 ]
Thakkinstian, A. [1 ]
机构：
[1] Mahidol Univ, Ramathibodi Hosp, Bangkok, Thailand
[2] Navamindradhiraj Univ, Fac Med Vajira Hosp, Dept Surg, Bangkok, Thailand
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.1221
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] SGLT2i and loop diuretic withdrawal or downtitration in heart failure
    Domingo, Mar
    Ruiz-Cueto, Maria
    Teis, Albert
    Lupon, Josep
    Alonso, Nuria
    Bayes-Genis, Antoni
    REVISTA ESPANOLA DE CARDIOLOGIA, 2023, 76 (11): : 943 - 945
  • [22] BENEFITS OF ADDING GLP1A TO SGLT2I THERAPY IN DIABETIC PATIENTS WITH ATHEROSCLEROTIC DISEASE AND HEART FAILURE
    Loyo, Persio Lopez
    Bohra, Chandrashekar
    Bhatia, Kirtipal
    Baruch, Lawrence
    Eng, Calvin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1447 - 1447
  • [23] Cardiorenal effects of SGLT2i in combination with ARNI for HFrEF: a systematic review and meta-analysis
    Cordovez, R. A. B.
    Rivera, K.
    Denila, R. A.
    Patricio, M.
    Permejo, C.
    EUROPEAN HEART JOURNAL, 2022, 43
  • [24] Quality of life in patients with heart failure and improved ejection fraction: one-year follow-up with ARNI and SGLT2i
    Tadic, S.
    Ilic, A.
    Stojsic-Milosavljevic, A.
    Stefanovic, M.
    Miljkovic, T.
    Bjelobrk, M.
    Kovacevic, M.
    Milovancev, A.
    Petrovic, M.
    Popov, T.
    Stojsic, S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [25] Pros and Cons of Inpatient SGLT2i Use for Hyperglycemia and Heart Failure
    Fried, Hayley
    Harris, Yael Tobi
    Schulman-Rosenbaum, Rifka
    JOURNAL OF THE ENDOCRINE SOCIETY, 2025, 9 (02)
  • [26] Drug Interaction of SGLT2Is and ARNI on Acute Kidney Injury: A Real-World Pharmacovigilance Analysis Through the FAERS
    Zhao, Subei
    He, Ronghua
    Mei, Mei
    Yu, Meng
    Yang, Zheng
    Tian, Chunyan
    Zhang, Ping
    Li, Rong
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2025, 85 (01) : 44 - 53
  • [27] Safety outcomes of SGLT2i in the heart failure trials: A systematic review and Meta-analysis
    Younes, Ahmed M.
    Salem, Mahmoud
    Maraey, Ahmed
    Nomigolzar, Soroush
    Sewell, Kerry
    Khalil, Mahmoud
    Elzanaty, Ahmed
    Saeyeldin, Ayman
    Dar, Moahad
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 366 : 51 - 56
  • [28] CLINICAL AND THERAPEUTIC CHARACTERISTICS OF PATIENTS WITH HEART FAILURE IN THERAPY WITH SGLT2I RELATED TO THE HEART FAILURE OUTPATIENT
    Benvenuto, M.
    Iacoviello, M.
    Gronda, E.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [29] SGLT2 inhibitors and vericiguat in real-world patients admitted for worsening heart failure
    Tarantini, R.
    Acone, L.
    Alonge, S.
    Catagnano, F.
    Foti, M.
    Oldani, M.
    Mortara, A.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [30] SGLT2 inhibitors in real-world patients with heart failure with preserved ejection fraction
    Tarantini, R.
    Vecchi, A. L.
    Matteo, F.
    De Ponti, R.
    Mortara, A.
    EUROPEAN HEART JOURNAL, 2022, 43 : 779 - 779
12345